Pneumococcal conjugate second or third-dose vaccines (PCVc) in Côte d’Ivoire
Côte d’Ivoire: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 59.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Côte d’Ivoire, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Côte d’Ivoire stood at 59.0%.
Compared with earlier readings it is up 3.5% on the previous year and down 15.7% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Côte d’Ivoire peaked at 82.0% in 2018 and was at its lowest, 0.0%, in 2008.
Côte d’Ivoire ranks 146th of 192 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 39.1% | 0.0% | 82.0% | 10 |
| 2020s | 60.5% | 57.0% | 68.0% | 6 |
Countries ranked near Côte d’Ivoire
- 145 North Macedonia 60.0% compare
- 146 Bolivia 59.0% compare
- 146 Philippines 59.0% compare
- 149 Madagascar 56.0% compare
More health data for Côte d’Ivoire
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Heat deaths vs projected death rates 864.4 (2090)
- Un projection of annual infant deaths 32,592 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 272,557 (2025)
- Age population, age 25, female, interpolated 247,365 (2025)
- Age population, age 24, male, interpolated 280,948 (2025)
- Age population, age 24, female, interpolated 254,808 (2025)
- Age population, age 23, male, interpolated 291,615 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Côte d’Ivoire?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Côte d’Ivoire was 59.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Côte d’Ivoire?
- The highest recorded value was 82.0% in 2018.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Côte d’Ivoire?
- The lowest recorded value was 0.0% in 2008.
- How does Côte d’Ivoire rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Côte d’Ivoire ranks 146th out of 192 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Côte d’Ivoire?
- Over the last ten years it is down 15.7%. The long-run trend across the full record is volatile.
- Where does this Côte d’Ivoire data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).